Heidi Brown, MD, of the UW Ob-Gyn Division of Female Pelvic Medicine and Reconstructive Surgery, published an invited editorial in the Journal of Women’s Health advocating for a balanced approach to emerging treatments.
In “When to Proceed with Caution: Balancing Promise with Prudence in the Treatment of Urinary Incontinence”, Brown discusses a recent study of a new intervention for stress urinary incontinence. The study she references is an early feasibility study of cryogen-cooled, monopolar radio frequency treatment for stress urinary incontinence. And while the study offers an exciting path forward, Brown urges us to be thoughtful about the study’s limitations and remember what has happened in the past with other exciting, new treatments:
“We must also learn from our history as a field. In our desire to offer women more durable and effective solutions for pelvic organ prolapse, we enthusiastically incorporated synthetic mesh augmentation at the time of surgical repair. With more robust studies of this technology, however, we realized that its benefits may not always outweigh its risks, leading the Food and Drug Administration (FDA) to classify vaginal mesh for anterior prolapse repair as class III, or ‘‘high risk,’’ in 2016.”
Read the rest of her incisive, thoughtful editorial here. Great work, Dr. Brown!